Global HIV Vaccine Shows Promise in Monkeys, Beth Israel Deaconess Medical Center Study
Published: Oct 25, 2013
The considerable diversity of HIV worldwide represents a critical challenge for designing an effective HIV vaccine. Now, a scientific team led by Beth Israel Deaconess Medical Center (BIDMC) has shown that bioinformatically optimized HIV vaccine antigens known as "mosaic" antigens might be useful in the design of a global HIV vaccine. This study, which was conducted in monkeys, is published today in the journal Cell.
Hey, check out all the research scientist jobs. Post your resume today!